|
If I understand the history of the herceptin trials correctly, they were massively overpowered because of advocacy groups, i.e., breast cancer advocacy groups were instrumental in getting as many patients included in the trial as possible. If it weren't for size of the trials, far fewer women would have had access to the drug. There weren't any other competitors to Herceptin at the time for adjuvent therapy, as far as I know.
__________________
dx 4/05 @ 34 y.o.
Stage IIIC, ER+ (90%)/PR+ (95%)/HER2+ (IHC 3+)
lumpectomy-- 2.5 cm 15+/37 nodes
(IVF in between surgery and chemo)
tx dd A/C, followed by dd Taxol & Herceptin
30 rads (or was it 35?)
Finished Herceptin on 7/24/06
Tamox
livingcured.blogspot.com
"Keep your face to the sunshine and you cannot see the shadow." -- Helen Keller
|
Hybrid Mode
